Mark S. Slaughter
Papers
2
Total Citations
55
H-Index
2
About
Dr. Mark S. Slaughter is a pioneering cardiothoracic surgeon whose career has been defined by advancing mechanical circulatory support and minimally invasive cardiac surgery. His most influential work centers on the development and clinical application of the total artificial heart (TAH) as a long-term destination therapy for patients with end-stage heart failure who are not candidates for transplantation. In his landmark 2022 paper, "The ongoing quest for the first total artificial heart as destination therapy" (43 citations), Dr. Slaughter critically evaluated the technological and clinical hurdles facing permanent TAH implantation, synthesizing decades of device evolution and patient outcomes to chart a roadmap for the field. Earlier, he made foundational contributions to robotic cardiac surgery, demonstrating in his 2003 study (12 citations) that peripheral cardiopulmonary bypass with modified assisted venous drainage and transthoracic aortic crossclamping could safely maintain hemodynamic stability and myocardial protection during robotic mitral valve repair—a technique that helped establish the feasibility of totally endoscopic heart surgery. Dr. Slaughter’s work has directly shaped how surgeons approach both temporary and permanent mechanical support, bridging the gap between experimental devices and routine clinical practice. His research continues to influence device design, patient selection criteria, and surgical protocols in advanced heart failure management.
Research Focus
Key Achievements
Top Papers
- 1
- 2